GC 4002B
Alternative Names: GC-4002BLatest Information Update: 03 Oct 2024
At a glance
- Originator GC Biopharma
- Class Influenza virus vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza virus infections